EUCTR2004-000573-54-IT进行中（未招募）不适用
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients with Type 2 Diabetes Mellitus
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ELI LILLY
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
An Open-Label Study Investigating Long-Term Safety and Tolerability of Nasalfent (Fentanyl Citrate Nasal Spray) in the Treatment of Breakthrough Cancer Pain (BTCP) in Subjects Taking Regular Opioid TherapyBreak ThroughCancer Pain10027656NL-OMON30752I3Research36
进行中（未招募）
不适用
An Open-Label Study Investigating Long-Term Safety andTolerability of Nasalfent (Fentanyl Citrate Nasal Spray) in theTreatment of Breakthrough Cancer Pain (BTCP) in SubjectsTaking Regular Opioid Therapy - NDtrattamento del dolore oncologico episodico intenso (Breakthrough Cancer Pain, BTCP,) nei soggetti in terapia analgesica con oppioidi assunta regolarmenteMedDRA version: 6.1Level: PTClassification code 10058019EUCTR2006-005403-34-ITARCHIMEDES500
招募中
3 期
ong-Term Safety Evaluation of Evinacumab in Patients Homozygous for Familial HypercholesterolemiaHomozygous familial hypercholesterolemiaJPRN-jRCT2051220184Makino Hisashi11
招募中
1 期
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of OMS906 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)Paroxysmal Nocturnal Hemoglobinuria (PNH)MedDRA version: 21.1Level: LLTClassification code: 10055629Term: Paroxysmal nocturnal hemoglobinuria Class: 10038359CTIS2023-507413-10-00Omeros Corp.26
进行中（未招募）
1 期
Open-Label Study of Long-Term Safety and Efficacy of Lanadelumab forPrevention of Acute Attacks of Non-histaminergic Angioedema withNormal C1-InhibitorEUCTR2019-004823-20-DETakeda Development Center Americas (TDCA)75